Physician profile
Mark Andy Lee
NPI 1730118225
$3,856.33
in general payments reported to CMS, 2019-2025
34 companies · $482 in 2025
The $482 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $301 · 2021: $697 · 2022: $818 · 2023: $608 · 2024: $454 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,543.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $976.05 | 2022-2025 | Azstarys |
| Pfizer INC. | $419.98 | 2019-2023 | |
| Tris Pharma INC | $363.04 | 2019-2025 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $300.60 | 2021-2023 | Qelbree |
| Neos Therapeutics, LP | $210.33 | 2019-2022 | |
| Glaxosmithkline, LLC. | $181.53 | 2022-2025 | Bexsero, Pediarix, Rotarix |
| Takeda Pharmaceuticals U.S.A., INC. | $170.44 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $151.68 | 2019-2023 | Jornay Pm |
| Merck Sharp & Dohme LLC | $141.94 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi Pasteur INC. | $139.35 | 2021-2025 | |
| Adlon Therapeutics L.P. | $127.20 | 2020-2021 | |
| Cranial Technologies, INC | $76.70 | 2019-2025 | Doc Band |
| Kaleo, INC. | $63.37 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $56.25 | 2025 | Jornay Pm |
| Seqirus USA INC | $55.75 | 2021-2025 | Flucelvax, Flucelvax Quadrivalent |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $41.97 | 2022 | |
| Novartis Pharmaceuticals Corporation | $38.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $37.89 | 2025 | |
| Baxter Healthcare | $26.49 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Lnhc, INC | $23.05 | 2025 | Zelsuvmi |
| Azurity Pharmaceuticals, INC. | $22.24 | 2025 | Alvesco |
| Biogen, INC. | $22.01 | 2021 | |
| Sobi, INC | $20.48 | 2019 | |
| Tempus Ai, INC | $20.44 | 2024 | |
| Medline Industries LP | $20.17 | 2024 | |
| Abbott Laboratories | $19.82 | 2024 | Id Now Instrument |
| Organon LLC | $18.95 | 2023 | Nexplanon |
| Astrazeneca Pharmaceuticals LP | $18.70 | 2025 | Fasenra |
| Teva Pharmaceuticals USA, INC. | $18.42 | 2019 | |
| Shire North American Group INC | $16.36 | 2019 | |
| Phadia US INC. | $15.99 | 2025 | Immunocap |
| Vertical Pharmaceuticals, LLC | $14.21 | 2019 | |
| Neurelis, INC. | $13.72 | 2023 | Valtoco |
| Arbor Pharmaceuticals, INC. | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.